{"title": "Vasomotor symptoms associated with menopause, Hot Flashes", "author": null, "url": null, "hostname": null, "description": "A study to learn more about how well elinzanetant works and how safe it is for the treatment of vasomotor symptoms (hot flashes) that are caused by hormonal ...", "sitename": "Vasomotor symptoms associated with menopause, Hot Flashes", "date": "2019-01-01", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Trial Condition(s):\nA study to learn more about how well elinzanetant works and how safe it is for the treatment of vasomotor symptoms (hot flashes) that are caused by hormonal changes over 26 weeks in women who have been through the menopause (OASIS-1)\n21651\nNot Available\nDie Forscher suchen nach einer besseren Methode zur Behandlung von Frauen, die nach der Menopause unter Hitzewallungen leiden. Hitzewallungen werden durch die hormonellen Ver\u00e4nderungen verursacht, die im K\u00f6rper einer Frau in der Menopause auftreten. Die Menopause ist der Zeitpunkt, an dem der Menstruationszyklus, auch Periode genannt, bei Frauen aufh\u00f6rt. Aufgrund des nat\u00fcrlichen Alterungsprozesses und der damit verbundenen hormonellen Umstellung produzieren die Eierst\u00f6cke w\u00e4hrend der Menopause immer weniger Sexualhormone. Der R\u00fcckgang der Hormonproduktion kann zu verschiedenen Symptomen f\u00fchren, die in manchen F\u00e4llen die Lebensqualit\u00e4t einer Frau in der Menopause stark beeintr\u00e4chtigen k\u00f6nnen.\nDie Studienbehandlung Elinzanetant wurde zur Behandlung von Symptomen entwickelt, die durch hormonelle Ver\u00e4nderungen verursacht werden. Es wirkt, indem es ein Protein namens Neurokinin daran hindert, Signale an andere Teile des K\u00f6rpers zu senden. Von Neurokinin wird angenommen, dass es eine gro\u00dfe Rolle bei der Ausl\u00f6sung von Hitzewallungen spielt. F\u00fcr Frauen, die die Menopause hinter sich haben, gibt es Medikamente gegen Hitzewallungen. Diese k\u00f6nnen jedoch bei manchen Frauen gesundheitliche Probleme verursachen.\nIn dieser Studie wollen die Forscher herausfinden, wie gut Elinzanetant im Vergleich zu einem Placebo bei solchen Frauen wirkt, die die Menopause hinter sich haben und unter Hitzewallungen leiden. Ein Scheinmedikament sieht wie ein Behandlungsmedikament aus, enth\u00e4lt aber keinen Wirkstoff. Um diese Studienbehandlungen zu vergleichen, werden die Teilnehmerinnen von den \u00c4rzten gebeten, Informationen \u00fcber ihre Hitzewallungen in einem elektronischen Tagebuch festzuhalten. Die Forscher untersuchen, wie h\u00e4ufig die Hitzewallungen bei den Teilnehmerinnen auftreten und wie stark sie sind. Sie werden die Ergebnisse vor der Behandlung und 4 Wochen sowie 12 Wochen nach der Behandlung betrachten.\nDie Teilnehmerinnen an dieser Studie nehmen einmal t\u00e4glich zwei Kapseln mit entweder Elinzanetant oder dem Placebo ein. Die Teilnehmerinnen, die Elinzanetant einnehmen, nehmen es 26 Wochen lang ein. Die Teilnehmerinnen, die das Placebo einnehmen, nehmen es 12 Wochen lang ein und nehmen dann die n\u00e4chsten 14 Wochen lang Elinzanetant ein.\nW\u00e4hrend der Studie werden die Teilnehmerinnen etwa 9-mal ins Pr\u00fcfzentrum kommen und einen Besuchstermin per Telefon durchf\u00fchren. Die Teilnehmer verbleiben voraussichtlich f\u00fcr einen Zeitraum von 36 Wochen in der Studie. Die Behandlung dauert 26 Wochen.\nW\u00e4hrend der Studie werden die Teilnehmerinnen:\n\u2022 record information about the participants\u2019 hot flashes in an electronic diary\n\u2022 answer questions about the participants\u2019 symptoms\nDie \u00c4rzte werden:\n\u2022 check the participants\u2019 health\n\u2022 take blood samples\n\u2022 ask the participants questions about what medicines the participants are taking and if the participants are having adverse events\nEin unerw\u00fcnschtes Ereignis ist jedes medizinische Problem, das ein Teilnehmer w\u00e4hrend einer Studie hat. \u00c4rzte zeichnen alle unerw\u00fcnschten Ereignisse auf, die in Studien auftreten, selbst wenn sie nicht glauben, dass die unerw\u00fcnschten Ereignisse mit den Studienbehandlungen in Zusammenhang stehen.\n- Postmenopausal, defined as: a. at least 12 months of spontaneous amenorrhea prior to signing of informed consent, or b. at least 6 months of spontaneous amenorrhea prior to signing of informed consent with serum follicle-stimulating hormone (FSH) levels > 40 mIU/mL and a serum estradiol concentration of < 30 pg/mL, or c. at least 6 months after hysterectomy at signing of informed consent with serum FSH levels > 40 mIU/mL and a serum estradiol concentration of < 30 pg/mL, or d. surgical bilateral oophorectomy with or without hysterectomy at least 6 weeks prior to signing of informed consent. - Moderate to severe hot flash (HF) associated with the menopause and seeking treatment for this condition. - Participant has completed Hot Flash Daily Diary (HFDD) for at least 11 days during the two weeks preceding baseline visit, and participant has recorded at least 50 moderate or severe HF (including night-time HF) over the last 7 days that the HFDD was completed (assessed at the Baseline Visit).\n- Any clinically significant prior or ongoing history of arrhythmias, heart block and QT prolongation either determined through clinical history or on ECG evaluation. - Any active ongoing condition that could cause difficulty in interpreting vasomotor symptoms (VMS) such as: infection that could cause pyrexia, pheochromocytoma, carcinoid syndrome. - Current or history (except complete remission for 5 years or more) of any malignancy (except basal and squamous cell skin tumors). Women receiving adjuvant endocrine therapy (e.g. tamoxifen, aromatase inhibitors, GnRH analogues) cannot be enrolled in this study. - Uncontrolled or treatment-resistant hypertension. Women with mild hypertension can be included in the study if these women are medically cleared prior to study participation. - Untreated hyperthyroidism or hypothyroidism. \u2022 Treated hyperthyroidism with no abnormal increase of thyroid function laboratory parameters and no relevant clinical signs for > 6 months before signing of informed consent is acceptable. \u2022 Treated hypothyroidism with normal thyroid function test results during screening and a stable (for \u2265 3 months before signing of informed consent) dose of replacement therapy is acceptable. - Any unexplained post-menopausal uterine bleeding. - Clinically relevant abnormal findings on mammogram. - Abnormal liver parameters. - Disordered proliferative endometrium, endometrial hyperplasia, polyp, or endometrial cancer diagnosed based on endometrial biopsy during screening.\n|Studienstandorte|\nStudienstandorte\nGynekologie MEDA s.r.o.\nBrno, Czech Republic, 602 00\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nAKH Wien | Allg. Gynaekologie & gynaekologische Onkologie\nWien, Austria, 1090\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nAKH Wien | Gyn. Endokrinologie & Reproduktionsmedizin\nWien, Austria, 1090\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nMedizinische Univ Graz | Frauenheilkunde & Geburtshilfe\nGraz, Austria, 8036\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nMedUni Innsbruck | Klinik fur Gyn Endo und Reproduktionsmed\nInnsbruck, Austria, 6020\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico\nMilano, Italy, 20122\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nA.O.U. Policlinico G.Rodolico-San Marco\nCatania, Italy, 95123\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nFondazione IRCCS Policlinico San Matteo\nPavia, Italy, 27100\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nOspedale San Raffaele s.r.l.\nMilano, Italy, 20132\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nA.O.U. Careggi\nFirenze, Italy, 50134\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nClinical Research of Philadelphia, LLC\nPhiladelphia, United States, 19114\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nWake Research, Inc.\nRaleigh, United States, 27612\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nSuncoast Clinical Research\nPalm Harbor, United States, 34684\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nWomen's Clinic of Lincoln, PC\nLincoln, United States, 68510\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nVenus Gynecology, LLC former Magnolia OB/GYN Research Center\nMyrtle Beach, United States, 29572\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nMesa Obstetricians and Gynecologists\nMesa, United States, 85206\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nPT-MEDICA s.r.o.\nPrachatice, Czech Republic, 383 01\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nSouthern Clinical Research Associates LLC\nMetairie, United States, 70001\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nOm Research, LLC\nLancaster, United States, 93534\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nCentricity Research formerly Aventiv - Columbus\nColumbus, United States, 43213\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nMount Vernon Clinical Research, LLC\nSandy Springs, United States, 30126\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nChattanooga Medical Research, LLC\nChattanooga, United States, 37404\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nCedar Health Research, LLC\nDallas, United States, 75251\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nCoastal Carolina Research Center\nMt. Pleasant, United States, 29464\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nWomen's Health Research Center, LLC\nLawrenceville, United States, 08648\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nDiagnamics, Inc.\nEncinitas, United States, 92024\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nAlliance for Multispecialty Research, LLC - Fort Meyers\nFort Myers, United States, 33912\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nUniversity Hospitals Landerbrook Health Center\nMayfield Heights, United States, 44124\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nSoapstone Center for Clinical Research\nDecatur, United States, 30034\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nUnited Women's Clinical Research - Lyndhurst\nWinston-Salem, United States, 27103\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nHillTop Obstetrics & Gynecology\nFranklin, United States, 45005-2593\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nContinental Clinical Solutions, LLC\nTowson, United States, 21204\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nSt. Vincent's Hospital - Birmingham\nBirmingham, United States, 35205\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nNoble Clinical Research\nTucson, United States, 85704\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nWomen Partners in Health Obstetrics & Gynecology (OB/GYN)\nAustin, United States, 78705\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nValley OB-GYN Clinic\nSaginaw, United States, 48602\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nOffice of Dr. James A. Simon, MD\nWashington, United States, 20036\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nMedical University of South Carolina\nCharleston, United States, 29425\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nBosque Womens Care\nAlbuquerque, United States, 87109\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nPhysician Care Clinical Research\nSarasota, United States, 34239\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nAlliance Research Institute\nTarzana, United States, 91356\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nHWC Women\u2019s Research Center\nEnglewood, United States, 45322\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nRutgers Robert Wood Johnson Medical School\nNew Brunswick, United States, 08901\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nMUDr. Stepan s.r.o.\nHradec Kralove, Czech Republic, 500 02\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nKestr-gyn s.r.o.\nNachod, Czech Republic, 547 01\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nDel Sol Research Management LLC\nTucson, United States, 85715\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nWake Research - Clinical Research Center of Nevada, LLC\nLas Vegas, United States, 89123\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nMomDoc Women For Women\nScottsdale, United States, 85251\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nA.O.U. Pisana\nPisa, Italy, 56126\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nG-Centrum Olomouc s.r.o. Dr. Skrivanek\nOlomouc, Czech Republic, 772 00\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nGynekologie Cheb s.r.o.\nCheb, Czech Republic, 350 02\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nSt. Antonius Ziekenhuis\nNieuwegein, Netherlands, 3435 CM\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nFlevoziekenhuis\nAlmere, Netherlands\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nDiakonessenhuis\nUTRECHT, Netherlands, 3582 KE\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nMedisense, Inc.\nAtlanta, United States, 30363\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nClinical Research Prime\nIdaho Falls, United States, 83404\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nHealth Corporation of Galilee Medical Center\nNahariya, Israel, 2210001\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nMeir Medical Center\nKfar Saba, Israel, 4428164\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nMayanei HaYeshua Medical Center\nBnei Brak, Israel, 5154475\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nHadassah Hebrew University Hospital Ein Kerem\nJerusalem, Israel, 9112001\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nJubilee Clinical Research, Inc\nLas Vegas, United States, 89106\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nARETAIEION University Hospital\nAthens, Greece, 11528\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nGeneral Hospital of Thessaloniki Papageorgiou\nThessaloniki, Greece, 56403\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nIoannina University General Hospital\nIoannina, Greece, 45500\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nUniversity General Hospital of Heraklion\nHeraklion, Greece, 711 10\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nCircuit Clinical OB/GYN Associates of WNY\nWest Seneca, United States, 14224\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nNAP-MED Egeszsegugyi Szolgaltato Kft\nDebrecen, Hungary, 4028\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nKomaromi Selye Janos Korhaz\nKomarom, Hungary, 2900\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nTritonlife Medical Center\nBudapest, Hungary, 1134\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nRub-Int Noi Egeszsegcentrum\nSzekesfehervar, Hungary, 8000\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nDebreceni Egyetem Klinikai Kozpont\nDebrecen, Hungary, 4032\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nGYN-MIKA s.r.o.\nCeske Budejovice, Czech Republic, 370 01\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nGYN-F s.r.o.\nHradec Kralove, Czech Republic, 500 03\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nThe Iowa Clinic - Ankeny\nAnkeny, United States, 50023\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nRevive Research Institute, Inc. - Women's Health\nDearborn Heights, United States, 48127\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nApplied Research Center of Arkansas\nLittle Rock, United States, 72212\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nOnSite Clinical Solutions, LLC\nCharlotte, United States, 28277\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nAxia Women's Health | Seven Hills Women's Health Centers - Montgomery\nCincinnati, United States, 45242\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nDrug Studies America\nMarietta, United States, 30060\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nParamount Research Solutions-College Park\nCollege Park, United States, 30349\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nSeattle Clinical Research Center\nSeattle, United States, 98105\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nOffice of Dr. Edmond Pack\nLas Vegas, United States, 89113\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nInvestigators Research Group, LLC\nBrownsburg, United States, 46112\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nMaximos Ob/Gyn\nLeague City, United States, 77573\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nNorthern California Research | Sacramento\nSacramento, United States, 95821\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nCentral Research Associates, Inc.\nBirmingham, United States, 35205\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nNortheast Clinical Research of San Antonio, LLC\nSan Antonio, United States, 78233\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nWomen's Care Research Institute/Marion OBGYN, Inc.\nMarion, United States, 43302\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nStudienstandorte\nVelocity Clinical Research - Albuquerque\nAlbuquerque, United States, 87107\nContact Us:\nE-mail:\nPhone: (+)1-888-84 22937\nA double-blind, randomized, placebo-controlled multicenter study to investigate efficacy and safety of elinzanetant for the treatment of vasomotor symptoms over 26 weeks in postmenopausal women\nTrial Type:\nInterventional\nIntervention Type:\nDrug\nTrial Purpose:\nTreatment\nAllocation:\nRandomized\nBlinding:\nN/A\nAssignment:\nParallel Assignment\nTrial Arms:\n2", "language": null, "image": "https://clinicaltrials.bayer.com/images/clinical_trials_explorer_logo.png", "pagetype": "website", "links": ["/", "/why-participate", "/#enhancingDiversity", "/what-are-clinical-trials", "/what-to-expect", "/transparency-policy", "https://www.facebook.com/sharer/sharer.php?u=", "https://twitter.com/share?url=", "https://www.linkedin.com/shareArticle?mini=true&url=", "/cdn-cgi/l/email-protection#a996dadccbc3cccadd94ebc8d0ccdb89dadddccdd089c6c789e4ccc7c6d9c8dcdacc8589ffc8dac6c4c6ddc6db89dad0c4d9ddc6c4da8981e1c6dd89cfc5c8dac1ccda808fc8c4d992cbc6cdd094e089c3dcdadd89cfc6dcc7cd89ddc1c8dd89ebc8d0ccdb89c1c8da89c889dadddccdd089cfc6db89d9ccc6d9c5cc89dec0ddc189e4ccc7c6d9c8dcdacc8589ffc8dac6c4c6ddc6db89dad0c4d9ddc6c4da8981e1c6dd89cfc5c8dac1ccda808c99ed8c99e8f0c6dc89cac8c789c5ccc8dbc789c4c6dbcc89cbd089cac5c0cac2c0c7ce89c6c789ddc1cc89c5c0c7c289cbccc5c6de8789", "https://clinicaltrials.gov/ct2/show/?term=NCT05042362&rank=1", "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2020-004908-33", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "/cdn-cgi/l/email-protection", "https://www.facebook.com/pharma.bayer/", "https://twitter.com/bayerpharma", "https://www.youtube.com/bayerpharma", "/terms-use", "/privacy-statement", "/contact-us", "/transparency-policy", "/sitemap"]}